BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 8664922)

  • 1. T1G3: What to do?
    Mandressi A
    Arch Ital Urol Androl; 1996 Feb; 68(1):5-7. PubMed ID: 8664922
    [No Abstract]   [Full Text] [Related]  

  • 2. The optimal management of T1G3 bladder cancer.
    Emiliozzi P; Pansadoro A; Pansadoro V
    BJU Int; 2008 Nov; 102(9 Pt B):1265-73. PubMed ID: 19035891
    [No Abstract]   [Full Text] [Related]  

  • 3. T1 and T2 bladder cancer: selecting optimal therapy.
    Soloway MS
    Eur Urol; 1998; 33 Suppl 4():16-7. PubMed ID: 9615202
    [No Abstract]   [Full Text] [Related]  

  • 4. [T1G3 bladder tumors: 5 years later].
    Pegoraro C; Bondovalli C; Dall'Oglio B; Schiavon L; Luciano M; Parma A
    Arch Ital Urol Androl; 1996 Feb; 68(1):35-8. PubMed ID: 8664919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T1G3 bladder cancer--the case for TUR and BCG.
    Miller K
    Front Radiat Ther Oncol; 2002; 36():147-50. PubMed ID: 11842744
    [No Abstract]   [Full Text] [Related]  

  • 6. [Conservative treatment of high-risk (T1G3) transitional carcinoma].
    Catanzaro F; Torelli F; Catanzaro M; Cappellano F; Pizzoccaro M; Baruffi M; Sironi D; Pozzoli GL
    Arch Ital Urol Androl; 1996 Feb; 68(1):21-4. PubMed ID: 8664915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [T1G3 bladder tumors: our experience].
    Pagano S; Franzoso F; Pachera F; Ruggeri P; Sorboli G
    Arch Ital Urol Androl; 1996 Feb; 68(1):39-45. PubMed ID: 8664920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [pT1G3 bladder carcinoma: our experience].
    Dell'Orto P; Trinchieri A; D'Addezio F; Bernardini P; Mangiarotti B; Del Nero A; Pisani E
    Arch Ital Urol Androl; 1996 Feb; 68(1):9-11. PubMed ID: 8664927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [T1G3 bladder neoplasms: treatment and results].
    Cosciani Cunico S; Magri V; Aulenti V; Tosana M; Botturi A
    Arch Ital Urol Androl; 1996 Feb; 68(1):47-50. PubMed ID: 8664921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [pT1G3 bladder carcinoma: parameters of a correct therapy].
    Ruoppolo M; Dell'Orto P; Fenice O; Seveso M; Ferri P; Zaatar C; Tagliaferri A; Cogni M; Bellorofonte G; Tombolini P
    Arch Ital Urol Androl; 1996 Feb; 68(1):17-20. PubMed ID: 8664914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indications for early cystectomy.
    Stein JP
    Urology; 2003 Oct; 62(4):591-5. PubMed ID: 14550424
    [No Abstract]   [Full Text] [Related]  

  • 12. [Intravesical adjuvant chemotherapy for superficial bladder cancer -- results of a survey in Saxony].
    Steinbach F; Schuster F
    Aktuelle Urol; 2005 Aug; 36(4):337-41. PubMed ID: 16110407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment and follow-up of superficial bladder cancer].
    Raitanen M
    Duodecim; 2002; 118(9):903-9. PubMed ID: 12238168
    [No Abstract]   [Full Text] [Related]  

  • 14. Difficult decisions in urologic oncology: management of high-grade T1 transitional cell carcinoma of the bladder.
    Soloway MS; Lee CT; Steinberg GD; Ghandi AA; Jewett MA
    Urol Oncol; 2007; 25(4):338-40. PubMed ID: 17628304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Superficial TCC bladder cancer: the impact of tumor differentiation on recurrence, progression and survival.
    Kurth KH
    Prog Clin Biol Res; 1984; 162A():307-18. PubMed ID: 6483914
    [No Abstract]   [Full Text] [Related]  

  • 16. High-risk superficial bladder cancer: intravesical therapy for T1 G3 transitional cell carcinoma of the urinary bladder.
    Pham HT; Soloway MS
    Semin Urol Oncol; 1997 Aug; 15(3):147-53. PubMed ID: 9394909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small cell carcinoma of the urinary bladder. A clinicopathologic analysis of 64 patients.
    Montie JE
    J Urol; 2005 Jun; 173(6):1920-1. PubMed ID: 15879778
    [No Abstract]   [Full Text] [Related]  

  • 18. T2a transitional cell carcinoma of the bladder: long-term experience with intravesical immunoprophylaxis with bacillus Calmette-Guerin.
    Volkmer BG; Gschwend JE; Maier SH; Seidl-Schlick EM; Bach D; Romics I
    J Urol; 2003 Mar; 169(3):931-4; discussion 934-5. PubMed ID: 12576815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrence and progression of T1G3 transitional cell carcinoma of the bladder treated with intravesical bacillus Calmette-Guérin.
    Günlüsoy B; Değirmenci T; Arslan M; Nergiz N; Minareci S; Ayder AR
    Urol Int; 2005; 75(2):107-13. PubMed ID: 16123562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Transitional carcinoma of the bladder at the T1G3 stage: personal experience].
    Roggia A; Pozzi E; Malvestiti GM
    Arch Ital Urol Androl; 1996 Feb; 68(1):25-8. PubMed ID: 8664916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.